Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.00 (0.00%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £3.80m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Director/PDMR Shareholding

13 Oct 2022 07:00

RNS Number : 7153C
Jarvis Securities plc
13 October 2022
 

Jarvis Securities plc

("Jarvis" or the "Company")

 

Directors' Dealing

 

On 12 October 2022, the Company was informed that, on that day:

 

· Mr Stephen Middleton, Non-Executive Director, purchased 10,000 Ordinary Shares in the Company at a price of 138 pence per share.

 

Following the transaction the combined interests held by Mr Middleton is 20,000 Ordinary Shares, representing 0.04% of the issued share capital of the Company.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stephen Middleton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jarvis Securities plc

b)

LEI

2138001WJI2OY3XHW269

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.25p

 

 

 

GB00BKS9NN22

b)

Nature of the transactions

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Type

Price(s)

Volume(s)

Purchase

138p

10,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

10,000

£13,800

e)

Date of the transaction

12 October 2022

f)

Place of the transaction

London Stock Exchange, AIM

 

 

ENDS

 

 

Enquiries:

 

Jarvis Securities plc 01892 510 515

Andrew Grant

Jolyon Head

 

WH Ireland Limited 0113 394 6600

Katy Mitchell

Darshan Patel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFDFUEEESEFS
Date   Source Headline
10th Aug 20237:00 amRNSDividend Declaration & Trading Update
13th Jul 20237:00 amRNSHalf-year Report
4th Jul 20232:57 pmRNSCompany Update
3rd Jul 20235:06 pmRNSHolding(s) in Company
3rd Jul 20235:04 pmRNSHolding(s) in Company
3rd Jul 20235:00 pmRNSHolding(s) in Company
3rd Jul 20234:59 pmRNSHolding(s) in Company
16th Jun 20238:59 amRNSHolding(s) in Company
16th Jun 20238:57 amRNSHolding(s) in Company
16th Jun 20238:54 amRNSHolding(s) in Company
11th May 20232:04 pmRNSDividend Declaration
20th Apr 20231:24 pmRNSResult of AGM
31st Mar 20237:00 amRNSCompany Update
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20232:05 pmRNSSecond Price Monitoring Extn
9th Mar 20232:00 pmRNSPrice Monitoring Extension
9th Mar 20237:00 amRNSResults for year ended 31 December 2022
8th Feb 20233:20 pmRNSDividend Declaration
10th Nov 20222:01 pmRNSDividend Declaration
13th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20225:11 pmRNSDirector/PDMR Shareholding
20th Sep 20229:05 amRNSSecond Price Monitoring Extn
20th Sep 20229:00 amRNSPrice Monitoring Extension
16th Sep 20222:39 pmRNSCompany Update
9th Aug 20223:15 pmRNSDividend Declaration
14th Jul 20227:00 amRNSHalf-year report
10th May 20223:36 pmRNSDividend Declaration
21st Apr 202211:30 amRNSResult of AGM
10th Mar 20227:00 amRNSResults for year ended 31 December 2021
15th Feb 20221:54 pmRNSDividend Declaration
15th Feb 20221:13 pmRNSDividend Declaration
9th Nov 20211:43 pmRNSDividend Declaration
10th Aug 20211:50 pmRNSDividend Declaration
16th Jul 202112:24 pmRNSShare Premium Cancellation & Dividend Declaration
15th Jul 20217:00 amRNSHalf-year Report
29th Jun 202112:27 pmRNSCancellation of Share Premium - Court approved
23rd Jun 20217:00 amRNSCancellation of Share Premium - Update
11th Jun 20211:03 pmRNSCancellation of Share Premium Update
12th May 20217:00 amRNSDividend Declaration
4th May 202112:45 pmRNSResult of General Meeting
26th Apr 20212:49 pmRNSNotice regarding COVID-19 and the General Meeting
22nd Apr 202110:36 amRNSResult of AGM
8th Apr 20217:00 amRNSResult of PrimaryBid Offer
7th Apr 20214:54 pmRNSPrimaryBid Offer, Notice of GM & Capital Reduction
30th Mar 20217:00 amRNSBoard Changes
19th Mar 20212:30 pmRNSTransaction in Own Shares
11th Mar 20217:00 amRNSResults for year ended 31 December 2020
16th Feb 202112:11 pmRNSDividend Declaration
3rd Feb 20211:31 pmRNSHolding(s) in Company
11th Dec 202010:19 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.